HOXA10 and pancreatic neoplasm: Mechanistically, HOXA10-AS knockdown effectively impedes HTR1D-induced malignant progression in PANC-1 and CFPAC-1 pancreatic cancer cells by acting as ceRNA for sponging miR-340-3p (Wu et al., 2022).